Takashi Fujita

Takashi Fujita

Auto-generated profile, based on publicly available information

Takashi Fujita

Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2023 in JMIR Formative Research
Verified
Journal Article
Open access
NKNari Kureyama
Nari Kureyama
MTMitsuo Terada
Mitsuo Terada
MKMaho Kusudo
Maho Kusudo
KNKazuki Nozawa
Kazuki Nozawa
YWYumi Wanifuchi-Endo
Yumi Wanifuchi-Endo
TTTatsuya Toyama
Tatsuya Toyama
Background: The widespread use of social media has made it easier for patients to access cancer information. However, a large amount of misinformation and harmful information that could negatively impact patients’ decision-making is also disseminated on social media platforms. Objective: We aimed to determine the actual amount of misinformation and harmful information as well as trends in the dissemination of cancer-related information on Twitter, a representative social media platform. Our findings can support decision-making among Japanese patients with cancer. Methods: Using the Twitter app programming interface, we extracted tweets containing the term “cancer” in Japanese that were posted between August and September of 2022. The eligibility criteria were the cancer-related tweets with the following information: (1) reference to the occurrence or prognosis of cancer, (2) recommendation or nonrecommendation of actions, (3) reference to the course of cancer treatment or adverse events, (4) results of cancer research, and (5) other cancer-related knowledge and information. Finally, we selected the top 100 tweets with the highest number of “likes.” For each tweet, 2 independent reviewers evaluated whether the information was factual or misinformation, and whether it was harmful or safe with the reasons for the decisions on the misinformation and harmful tweets. Additionally, we examined the frequency of information dissemination using the number of retweets for the top 100 tweets and investigated trends in the dissemination of information. Results: The extracted tweets totaled 69,875. Of the top 100 cancer-related tweets with the most “likes” that met the eligibility criteria, 44 (44%) contained misinformation, 31 (31%) contained harmful information, and 30 (30%) contained both misinformation and harmful information. Misinformation was described as Unproven (29/94, 40.4%), Disproven (19/94, 20.2%), Inappropriate application (4/94, 4.3%), Strength of evidence mischaracterized (14/94, 14.9%), Misleading (18/94, 18%), and Other misinformation (1/94, 1.1%). Harmful action was described as Harmful action (9/59, 15.2%), Harmful inaction (43/59, 72.9%), Harmful interactions (3/59, 5.1%), Economic harm (3/59, 5.1%), and Other harmful information (1/59, 1.7%). Harmful information was liked more often than safe information (median 95, IQR 43-1919 vs 75.0 IQR 43-10,747; P=.04). The median number of retweets for the leading 100 tweets was 13.5 (IQR 0-2197). Misinformation was retweeted significantly more often than factual information (median 29.0, IQR 0-502 vs 7.5, IQR 0-2197; P=.01); harmful information was also retweeted significantly more often than safe information (median 35.0, IQR 0-502 vs 8.0, IQR 0-2197; P=.002). Conclusions: It is evident that there is a prevalence of misinformation and harmful information related to cancer on Twitter in Japan and it is crucial to increase health literacy and awareness regarding this issue. Furthermore, we believe that it is important for government agencies and health care professionals to continue providing accurate medical information to support patients and their families in making informed decisions.

4 February 2026 in Surgical Oncology
Verified
Journal Article
Closed access
YNYuka Niwa
Yuka Niwa
MTMitsuo Terada
Mitsuo Terada
YWYumi Wanifuchi-Endo
Yumi Wanifuchi-Endo
TFTakashi Fujita
Takashi Fujita
TATomoko Asano
Tomoko Asano
TTTatsuya Toyama
Tatsuya Toyama

24 May 2025 in Breast Cancer
Verified
Journal Article
Closed access
PDF file
AIAyaka Isogai
Ayaka Isogai
MTMitsuo Terada
Mitsuo Terada
YWYumi Wanifuchi-Endo
Yumi Wanifuchi-Endo
TFTakashi Fujita
Takashi Fujita
TATomoko Asano
Tomoko Asano
TTTatsuya Toyama
Tatsuya Toyama

31 May 2023 in JMIR Preprints
Verified
Preprint
Open access
NKNari Kureyama
Nari Kureyama
MTMitsuo Terada
Mitsuo Terada
MKMaho Kusudo
Maho Kusudo
KNKazuki Nozawa
Kazuki Nozawa
YWYumi Wanifuchi-Endo
Yumi Wanifuchi-Endo
TTTatsuya Toyama
Tatsuya Toyama
BACKGROUND The widespread use of social media has made it easier for patients to access cancer information. However, a large amount of misinformation and harmful information that could negatively impact patients’ decision-making is also disseminated on social media platforms. OBJECTIVE We aimed to determine the actual amount of misinformation and harmful information as well as trends in the dissemination of cancer-related information on Twitter, a representative social media platform. Our findings can support decision-making among Japanese patients with cancer. METHODS Using the Twitter app programming interface, we extracted tweets containing the term “cancer” in Japanese that were posted between August and September of 2022. The eligibility criteria were the cancer-related tweets with the following information: (1) reference to the occurrence or prognosis of cancer, (2) recommendation or nonrecommendation of actions, (3) reference to the course of cancer treatment or adverse events, (4) results of cancer research, and (5) other cancer-related knowledge and information. Finally, we selected the top 100 tweets with the highest number of “likes.” For each tweet, 2 independent reviewers evaluated whether the information was factual or misinformation, and whether it was harmful or safe with the reasons for the decisions on the misinformation and harmful tweets. Additionally, we examined the frequency of information dissemination using the number of retweets for the top 100 tweets and investigated trends in the dissemination of information. RESULTS The extracted tweets totaled 69,875. Of the top 100 cancer-related tweets with the most “likes” that met the eligibility criteria, 44 (44%) contained misinformation, 31 (31%) contained harmful information, and 30 (30%) contained both misinformation and harmful information. Misinformation was described as Unproven (29/94, 40.4%), Disproven (19/94, 20.2%), Inappropriate application (4/94, 4.3%), Strength of evidence mischaracterized (14/94, 14.9%), Misleading (18/94, 18%), and Other misinformation (1/94, 1.1%). Harmful action was described as Harmful action (9/59, 15.2%), Harmful inaction (43/59, 72.9%), Harmful interactions (3/59, 5.1%), Economic harm (3/59, 5.1%), and Other harmful information (1/59, 1.7%). Harmful information was liked more often than safe information (median 95, IQR 43-1919 vs 75.0 IQR 43-10,747; P=.04). The median number of retweets for the leading 100 tweets was 13.5 (IQR 0-2197). Misinformation was retweeted significantly more often than factual information (median 29.0, IQR 0-502 vs 7.5, IQR 0-2197; P=.01); harmful information was also retweeted significantly more often than safe information (median 35.0, IQR 0-502 vs 8.0, IQR 0-2197; P=.002). CONCLUSIONS It is evident that there is a prevalence of misinformation and harmful information related to cancer on Twitter in Japan and it is crucial to increase health literacy and awareness regarding this issue. Furthermore, we believe that it is important for government agencies and health care professionals to continue providing accurate medical information to support patients and their families in making informed decisions. CLINICALTRIAL

1 May 2026 in Journal of Pain Research
Verified
Journal Article
Open access
MSMie Sakai
Mie Sakai
TTTatsuya Toyama
Tatsuya Toyama
HHHiroya Hashimoto
Hiroya Hashimoto
TUTaro Ueno
Taro Ueno
YWYumi Wanifuchi-Endo
Yumi Wanifuchi-Endo
TATatsuo Akechi
Tatsuo Akechi
This study examined the feasibility and potential acceptability, with exploratory assessment of its effects on pain interference and fear of recurrence, of a smartphone-based acceptance and commitment therapy (ACT) intervention to reduce pain interference and fear of recurrence in breast cancer survivors. This single-center, parallel-group, randomized controlled pirot trial included breast cancer survivors with postmastectomy pain syndrome who were randomly allocated to an ACT intervention group or control group in a 1:1 ratio. Of the 57 patients screened, 45 were randomly assigned to the ACT group (n = 22) and the control group (n = 23). The ACT app offered an 8-week program with outcome measures for before and after the intervention. Primary outcomes were feasibility and adherence, assessed by intervention completion rate, participants’ perceived usefulness, and satisfaction. Secondary outcomes included exploratory clinical measures assessed before and after the intervention. The intervention completion rate for the ACT group was 100%, and the degree to which patients’ needs were met and their overall satisfaction was high (>60%). One minor adverse event was reported, but the patient had already recovered by the time of the interview stage, and the event was considered minor. No significant improvements were observed in clinical outcomes. The results demonstrate the feasibility and acceptability of smartphone-based ACT interventions. Clinical efficacy was not demonstrated and should be evaluated in future trials with adequately powered samples and participants with higher levels of pain interference.